Eton Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:ETON) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 76.12 M84.03 M101.68 M104.51 M92.11 M Total liabilities 51.7 M59.58 M77.72 M81.38 M65.96 M Total equity 24.43 M24.45 M23.96 M23.13 M26.15 M Total liabilities & shareholders' equities 76.12 M84.03 M101.68 M104.51 M92.11 M Total debt 29.99 M30.16 M30.18 M30.37 M30.56 M Net debt 15.06 M12.74 M4.8 M-6.75 M4.62 M

Haberler

Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating

Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating

Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Dow Jones Futures: Trump's Iran Comments Spark Stock Market Rally; Micron, Nvidia, Palantir, Tesla Are Big Movers

Stock Market Today: Dow Up As These Leisure Plays Cruise Higher; Pharma Stock Clears Entry (Live Coverage)

H.C. Wainwright, Eton Pharmaceuticals için hedef fiyatı yükseltti

B.Riley, Eton Pharmaceuticals için hedef fiyatı yükseltti

Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript

Eton Pharmaceuticals 4Ç 2025 kazancı beklentiyi aştı, hisse yükseldi

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Eton Pharmaceuticals kazancı $0,01 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük

Ovid Therapeutics (OVID) Q4 Earnings and Revenues Surpass Estimates